A New Opportunity This year saw the rise of powerful new weight loss drugs such as Novo Nordisk’s (NVO) Ozempic and Wegovy. But food companies are seeing an opportunity. These new drugs work by suppressing appetites, which has left many investors bearish on food suppliers as more Americans begin taking these drugs. However, savvy food…閱讀更多
